Prospective Comparison of the Carbon Footprint of EUS vs MRCP for Evaluation of Suspected Choledocholithiasis
Prospective Comparison of the Carbon Footprint of Endoscopic Ultrasound (EUS) vs Magnetic Resonance Cholangiopancreatography (MRCP) for Evaluation of Suspected Choledocholithiasis
Asian Institute of Gastroenterology, India
200 participants
Dec 1, 2025
OBSERVATIONAL
Conditions
Summary
MRCP and EUS are diagnostically equivalent in detecting CBD stones among patients with intermediate risk, as shown in a landmark RCT. However, MRI-based imaging is power-intensive, requiring large infrastructure and long scan durations. EUS, a less energy-consuming and portable procedure, has the added advantage of enabling same-session ERCP, reducing the need for repeat procedures.
Eligibility
Inclusion Criteria3
- Age ≥18 years
- Intermediate likelihood of CBD stone (per ESGE)
- Undergoing either MRCP or EUS for evaluation
Exclusion Criteria3
- High or low likelihood category (per ESGE)
- Undergoing both MRCP and EUS simultaneously
- Contraindications to either modality
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07283185